Lifebank Corp. (the "Company") (TSX VENTURE:LBK) announces that, under its stock
option plan, it has granted incentive stock options to directors, officers and
consultants of the Company to purchase up to a total aggregate of 575,000 Common
shares in the capital stock of the Company at a price of $0.20 per share. The
options are exercisable until January 8, 2013.


Lifebank is a biomedical service company that provides processing and cryogenic
(ultra low temperature) storage of umbilical cord blood stem cells. It is an
AABB accredited, Health Canada inspected and FDA registered facility. Lifebank
has successfully stored stem cell samples for clients in Canada, the United
States, Europe, Asia, the Middle East and the Caribbean. Lifebank is dedicated
to providing its clients with the finest cord blood stem cell processing,
analysis and cryogenic storage services available in the world. Lifebank strives
to work closely with physicians and public institutions in order to provide life
saving cord blood services to any and all persons in need.
Lifebank Corp. (TSXV:LBK)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Lifebank Corp. Charts.
Lifebank Corp. (TSXV:LBK)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Lifebank Corp. Charts.